Companies / Enliven Therapeutics, Inc.

Enliven Therapeutics, Inc.

Nasdaq: ELVNCIK 1672619BURLINGAME, CA

Financials

Revenue—
Net income$-103.69M
Total debt—
Cash$135.50M
Diluted EPS$-1.83
Shares outstanding73.3M

Ownership

73.3M shares outstanding · as of Jul 28, 2026
0.07%Insiders
Ownership
Insiders0.07%47,647
10%+ / strategic8.95%6,555,102
Institutions77.21%56,575,118
Public float13.77%10,092,894

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 14

View all →
Insider% of sharesShares
Orbimed Advisors LLC10% owner
8.95%6,555,102
Lyssikatos Joseph PFormerCHIEF SCIENTIFIC OFFICER
1.04%758,938
Patel AnishFormerCHIEF OPERATING OFFICER
0.32%235,011
Hohl BenjaminFormerCHIEF FINANCIAL OFFICER
0.07%51,000
Collins Helen LouiseCHIEF MEDICAL OFFICER
0.03%25,000
Heyman Richard A.Director
0.03%22,647
Ballal Rahul D.Director
——
Bauer JakeDirector
——
Derynck Mika KDirector
——
Garland J. ScottDirector
——

Institutional holders 143

View all →
HolderValue% of shares
Orbimed Advisors LLC$312.01M10.86%
BlackRock, Inc.$221.25M5.95%
Fmr LLC$109.46M9.70%
Commodore Capital LP$72.27M6.40%
State Street Corporation$61.59M1.66%
Vestal Point Capital, LP$58.98M5.23%
Fairmount Funds Management LLC$57.16M5.07%
Polar Capital Holdings Plc$54.11M4.80%
Novo Holdings A/S$50.18M1.75%
VR Adviser, LLC$49.69M4.40%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 22, 2026Orbimed Advisors LLC
10% owner
SellCommon Stock$35.72M-787K
-10.65%
6,601,878
9.01% of shares
high
Jun 15, 2026Orbimed Advisors LLC
10% owner
SellCommon Stock$12.26M-272K
-3.55%
7,388,902
10.08% of shares
high
Jun 22, 2026Orbimed Advisors LLC
10% owner
SellCommon Stock$2.10M-47K
-0.71%
6,555,102
8.95% of shares
medium
Jan 9, 2026Lyssikatos Joseph P
Executive
SellCommon Stock$1.46M-50K
-6.13%
765,188
1.04% of shares
medium
Mar 25, 2026Collins Helen Louise
Executive
SellCommon Stock$1.40M-40K
-61.54%
25,000
0.03% of shares
medium
Jan 9, 2026Patel Anish
Executive
SellCommon Stock$1.34M-48K
-18.25%
215,254
0.29% of shares
medium
Feb 17, 2026Collins Helen Louise
Executive
SellCommon Stock$1.18M-45K
-64.29%
25,000
0.03% of shares
medium
Jun 22, 2026Orbimed Advisors LLC
10% owner
SellCommon Stock$1.13M-25K
-10.11%
220,882
0.30% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vestal Point Capital, LPPassive13G———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ELVNCommon StockEquity29337E102BBG00CP3BDD4